| Affimed–Leucadia: investor conference, 201906 supply service Affimed presents at Jefferies 2019 Global Healthcare Conference NY |
2019-06-05 |
| Medigene–Leucadia: investor conference, 201906 supply service Medigene presents at Jefferies Global Healthcare Conference NY |
2019-06-04 |
| Spindiag–SEVERAL: investment, 201906 financing round Series A exansion additional €4m incl new investor WBG Pflegeheime |
2019-06-04 |
| Bruker Corp–PreOmics: sample preparation technology, 201905– collab developm + marketing PreOmics iST sample preparation on timsTOF Pro MS system |
2019-05-31 |
| BlueHaven Therapeutics–MC Services: public relations, 201905 service existent IR by MC Services |
2019-05-30 |
| Cubuslab–Labfolder: investment, 201905 acquisition merger of Cubuslab Gmbh + Labfolder GmbH + new name Labforward GmbH |
2019-05-22 |
| Confo Therapeutics–Wellington Partners: investment, 201905 financing round Series A totalling €30m incl new + co-lead investor Wellington Partners |
2019-05-07 |
| InfanDx–Arnika Beteiligungen: investment, 201904 financing round totalling up to €5.3m incl existing + co-investor Arnika Beteiligungen GmbH |
2019-04-24 |
| Immunic–Needham: investor conference, 201904 supply service Immunic presents at Annual Needham Healthcare Conference in NY |
2019-04-10 |
| DKSH–Bruker Corp: analytical instruments, 201904– distribution excl extension for Bruker AXS products by DKSH in China |
2019-04-09 |
| 4SC–HC Wainwright: investor conference, 201904 supply service 4SC presents at HC Wainwright Global Life Sciences Conference in London |
2019-04-07 |
| Phenex–Helmholtz: drug research, 201904– collab joint research in NASH + liver cancer metabolism with Heikenwälder Group at DKFZ |
2019-04-05 |
| Immunic–Rx Communications: public relations, 201904 service existent by Rx Communications Group |
2019-04-02 |
| Cytena–High-Tech Gründerfonds: investment, 201903 financing round Series A totalling €3.m incl HTGF + two private investors |
2019-03-26 |
| Cytena–SEVERAL: investment, 201903 financing round Series A €3.m from HTGF + two private investors |
2019-03-26 |
| Arxspan–Bruker Corp: investment, 201903 acquisition €na of Arxspan LLC by Bruker Corp |
2019-03-14 |
| Snipr Biome–Wellington Partners: investment, 201903 financing round Series A totalling $50m incl co-investor Wellington Partners |
2019-03-11 |
| abcr GmbH–Enzymicals: enzymes, 201903– collab distribution expansion ww sale of all catalogue products of Enzymcials by acbr |
2019-03-04 |
| CEPI–CureVac: mRNA vaccine production technology, 201903–202202 collab up to $34m developm of mobile mRNA printing facility |
2019-03-01 |
| CureVac–Silicon Valley Bank: investor conference, 201902 supply service CureVac presents at SVB Leerink Global Healthcare Conference in NYC |
2019-02-27 |
| Plasmion–Bavaria (govt): investment, 201902 financing round totalling almost €1m from HTGF + BayBG + business angel |
2019-02-14 |
| Plasmion–High-Tech Gründerfonds: investment, 201902 financing round totalling almost €1m from HTGF + BayBG + business angel |
2019-02-14 |
| Plasmion–PERSON: investment, 201902 financing round totalling almost €1m from HTGF + BayBG + business angel |
2019-02-14 |
| Plasmion–SEVERAL: investment, 201902 financing round almost €1m from HTGF + BayBG + business angel |
2019-02-14 |
| Apceth–Hitachi: investment, 201901–201904 acquisition €75.5m 100% of Apceth Biopharma GmbH from Apceth GmbH by Hitachi Chemical |
2019-01-31 |
| Medizinsches Labor Hannover–Labor Limbach: investment, 201901 acquisition 100% of MLH by Limbach Gruppe SE PENDING |
2019-01-26 |
| MAB Discovery–BioNTech: investment, 201901–201903 acquisition €na of Antibody Generation Unit of MAB Discovery by BioNTech |
2019-01-23 |
| Mecuris–Bavaria (govt): investment, 201901 financing round Series A totalling €3.6m incl existing investor Bayern Kapital GmbH |
2019-01-16 |
| Mecuris–High-Tech Gründerfonds: investment, 201901 financing round Series A totalling €3.6m incl existing investor HTGF |
2019-01-16 |
| Mecuris–Mulcan: investment, 201901 financing round Series A totalling €3.6m incl new investor MII Mulcan International Investments GmbH |
2019-01-16 |
| Mecuris–OTHER: investment, 201901 financing round Series A totalling €3.6m incl new investor one of largest German hospital chains |
2019-01-16 |
| Mecuris–SEVERAL: investment, 201901 financing round Series A €3.6m incl Bayern Kapital + HTGF + Vesalius Biocapital + Mulcan et al. |
2019-01-16 |
| Mecuris–Vesalius Biocapital: investment, 201901 financing round Series A totalling €3.6m incl new investor Vesalius Biocapital III SICAR |
2019-01-16 |
| Affimed–JPMorgan Chase: investor conference, 201901 supply service Affimed presents at JP Morgan Healthcare Conference 2019 |
2019-01-10 |
| Denali Therapeutics–Sirion Biotech: gene delivery technology, 201901– license + collab develop AAV vectors for CNS diseases that could cross BBB |
2019-01-09 |
| CureVac–Global Health PR: public relations, 201809 service existent media relations by Global Health PR |
2019-01-08 |
| Medigene–Helmholtz: cell therapy, 201901– license to co-stimulator to enhance TCR therapies for solid tumours from HMGU |
2019-01-04 |
| Atriva Therapeutics–High-Tech Gründerfonds: investment, 201901 financing round Series A first closing led by Meneldor + HTGF |
2019-01-03 |
| Atriva Therapeutics–MC Services: public relations, 201901 service existent by MC Services |
2019-01-03 |
| Atriva Therapeutics–Meneldor: investment, 201901 financing round Series A first closing led by Meneldor + HTGF |
2019-01-03 |
| Atriva Therapeutics–SEVERAL: investment, 201901 financing round Series A first closing led by Meneldor + HTGF |
2019-01-03 |
| Evitria–SHS: investment, 201812 acquisition majority stake by Afinum Achte Beteiligungs GmbH & Co KG + SHS V Medtech Investments GmbH |
2018-12-20 |
| Novartis–Curetis: antibiotics research, 201812– collab Sandoz to use Ares Genetics’ antibiotic resistance database ARESdb |
2018-12-18 |
| PreOmics–High-Tech Gründerfonds: investment, 201812 financing round Series A totalling €3.3m incl HTGF + Think.Health Ventures + business angels |
2018-12-18 |
| PreOmics–SEVERAL: investment, 201812 financing round Series A €3.3m from HTGF + Think.Health Ventures + business angels |
2018-12-18 |
| PreOmics–Think.Health Ventures: investment, 201812 financing round Series A totalling €3.3m incl HTGF + Think.Health Ventures + business angels |
2018-12-18 |
| Orchard Therapeutics–Sirion Biotech: gene therapy manufacturing technology, 201812– license for stem cell gene therapies |
2018-12-14 |
| AC Immune–Hopp Group: investment, 201812 existent investment dievini Hopp owns 27% of AC Immune SA |
2018-12-05 |
| Apogenix–Hopp Group: investment, 201812 existent investment dievini Hopp owns 92% of Apogenix AG |
2018-12-05 |
| Cassiopea–Hopp Group: investment, 201812 existent investment dievini Hopp owns 1% of Cassiopea SpA |
2018-12-05 |
| Cosmo Pharmaceuticals–Hopp Group: investment, 201812 existent investment dievini Hopp owns 5% of Cosmo SpA |
2018-12-05 |
| CureVac–Hopp Group: investment, 201812 existent investment dievini Hopp owns 80% of CureVac AG |
2018-12-05 |
| Heidelberg Pharma–Hopp Group: investment, 201812 existent investment dievini Hopp owns 83% of Heidelberg Pharma AG |
2018-12-05 |
| Immatics–Hopp Group: investment, 201812 existent investment dievini Hopp owns 38% of Immatics GmbH |
2018-12-05 |
| Joimax–Hopp Group: investment, 201812 existent investment dievini Hopp owns 85% of Joimax GmbH |
2018-12-05 |
| Molecular Health–Hopp Group: investment, 201812 existent investment dievini Hopp owns 95% of Molecular Health GmbH |
2018-12-05 |
| Novaliq–Hopp Group: investment, 201812 existent investment dievini Hopp owns 93% of Novaliq GmbH |
2018-12-05 |
| CureVac–Piper Jaffray: investor conference, 201811 supply service CureVac presents at Piper Jaffray Healthcare Conference 2018 |
2018-11-27 |
| Spindiag–SEVERAL: investment, 201811 financing round Series A €3m |
2018-11-27 |
| Adrenomed–MC Services: public relations, 201811 service existent by MC Services |
2018-11-26 |
| Adrenomed–Wellington Partners: investment, 201811 financing round Series D totalling €24m incl new + co-lead investor Wellington Partners |
2018-11-26 |
| Quarton International–Cowen: investment, 201811–201901 acquisition of Quarton by Cowen |
2018-11-20 |
| I-Mab–MorphoSys: antibody cancer drug, 201811– license excl Greater China + KR for MOR210 with $3.5m upfront + $101.5m milestones + royalties |
2018-11-15 |
| Virion Biotherapeutics–Trophic Communications: public relations, 201811 service existent by Trophic |
2018-11-14 |
| Omeicos–Forbion: investment, 201811 financing round Series C totalling €17m incl new + lead investor Forbion |
2018-11-02 |
| HBM–CMS: legal services, 201811 supply service legal advice by CMS for both lead investors HBM + Wellington of Adrenomed Series D round |
2018-11-01 |
| Wellington Partners–CMS: legal services, 201811 supply service legal advice by CMS for both lead investors HBM + Wellington of Adrenomed Series D |
2018-11-01 |
| Quantum Analytics–Bruker Corp: analytical instruments, 201810– distribution of S2 Puma + S2 Polar + D2 Phaser analysers in the US by Quantum Analytics |
2018-10-16 |
| Gotham Therapeutics–MacDougall Biomedical Communications: public relations, 201810 service existent by MacDougall |
2018-10-10 |
| Sphingotec–Wellington Partners: investment, 201810 financing round totalling €20m incl co-lead investor Wellington Partners |
2018-10-08 |
| B Braun–CeGaT: personalised medicine, 201810 collab establishment JV to develop personalised cancer vaccines CeCaVa GmbH & Co KG |
2018-10-01 |
| Helmholtz–Bruker Corp: MRI system, 201810 supply 9.4 Tesla preclinical MRI system with integrated PET detector to DKFZ |
2018-10-01 |
| Novaliq–Hopp Group: investment, 201810 financing round €44.9m from Dievini Hopp BioTech Holding GmbH |
2018-10-01 |
| Evotec–Berenberg: investor conference, 201809 supply service Evotec attends 7th German Corporate Conference in Munich |
2018-09-26 |
| Evotec–Baader Bank: investor conference, 201809 supply service Evotec attends Baader Investment Conference 2018 in Munich |
2018-09-24 |
| Plug and Play–Roche: healthcare, 201809–202108 collab creation of Startup Creasphere innovation program in Munich with Roche Diagnostics |
2018-09-20 |
| Merck (DE)–AstraZeneca: digital pathology, 201809– collab multi-year partnership with Definiens using TissuePhenomics for biomarker quantification |
2018-09-10 |
| RSP Systems–Trumpf: investment, 201809 financing round Series B 2nd closing totalling €3.85m incl new investor Trumpf Venture GmbH |
2018-09-10 |
| Affimed–Wells Fargo: investor conference, 201809 supply service Affimed presents at Wells Fargo Healthcare Conference in Boston |
2018-09-06 |
| Roche–Affimed: antibody cancer drug, 201808– collab $96m ufpront + $5b milestones + royalties using ROCK platform to develop ABs with Genentech |
2018-08-27 |
| Hain Lifescience–Bruker Corp: investment, 201808– acquisition €na of 80% majority interest with option to acquire rest in 2012 ANNOUNCED |
2018-08-24 |
| Univ Warwick–Bruker Corp: NMR spectrometer, 201808 supply Avance 1.0 GHz solid-state NMR spectrometer |
2018-08-06 |
| Biocrates–MC Services: public relations, 201807 service existent by MC Services |
2018-07-25 |
| SHS–SEVERAL: investment, 201807 first closing €90m of SHS V fund with target size of €150m |
2018-07-20 |
| Novartis–MorphoSys: therapeutic antibody, 201807– license excl ww to MOR106 from MOR+GLPG €95m upfront + €850m milestones + royalties + funding |
2018-07-19 |
| Adocia–MC Services: public relations, 201807 service existent PR Europe by MC Services |
2018-07-18 |
| B Braun–CeGaT: personalised medicine, 201807 collab establishment of B Braun Precision Medicine Technology (Shanghai) Ltd |
2018-07-17 |
| CeGaT–B Braun: investment, 201807 existent 30% shareholding of B Braun in CeGaT |
2018-07-17 |
| Polares Medical–Wellington Partners: investment, 201807 financing round totalling $25m incl co-investor Wellington Partners |
2018-07-17 |
| Genmab–Immatics: cancer immunotherapy, 201807– researc collab + excl license to targets for biospecific I-O drugs $54m upfront + $550m milestones |
2018-07-12 |
| BioNTech–Trophic Communications: public relations, 201807 service existent German media relations by Trophic |
2018-07-10 |
| IMMUNOMONITOR project–Biomax: pharmacogenomics, 201807– collab partner in Eurostars project to develop validation treatm response to cancer vaccines |
2018-07-05 |
| Curetis–Goetzpartners: investor conference, 201806 supply service Curetis presents at Goetzpartners Healhlcare Day 2018 in London |
2018-06-22 |
| Sartorius–Siemens: automation technology, 201806– collab long-term using Siemens automation for SSB’s bio production offerings |
2018-06-12 |
| Treeway–Trophic Communications: public relations, 201805 service existent by Trophic |
2018-05-29 |
| Medigene–SEVERAL: investment, 201805 private placement €32.3m 2.23m new shares at €14.5/share to institutional investors |
2018-05-24 |
| Lava Therapeutics–Trophic Communications: public relations, 201805 service existent by Trophic |
2018-05-23 |
| Acousia Therapeutics–Boehringer: investment, 201805 financing round Series B totalling €10m incl existing + co-investor BIVF |
2018-05-14 |
| Acousia Therapeutics–Bregua Corp: investment, 201805 financing round Series B totalling €10m incl new + co-investor Bregua Corp |
2018-05-14 |
| Acousia Therapeutics–Creathor Venture: investment, 201805 financing round Series B totalling €10m incl new + co-investor Creathor Venture |
2018-05-14 |
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo-2019.png){kind=logo}
Date![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 600x60px](/banner/iito-20181119-600-060-lse-life-sciences-europe-com.jpg)
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20111029-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
